
    
      This study is a randomized, double-blinded, efficacy trial of the effects of udenafil vs.
      placebo on the background of standard therapy on maximal VO2 (ml/kg/min) from baseline to six
      months in adolescent survivors of the Fontan procedure. . The target sample size is 400
      subjects (200 per group).
    
  